Summary of clinical studies with the Oka live varicella vaccine produced by Smith Kline-RIT.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000096:biosynthesis; D002644:Chickenpox / Q000517:prevention & control*; D002648:Child; D002675:Child, Preschool; D004797:Enzyme-Linked Immunosorbent Assay; D005455:Fluorescent Antibody Technique; D014645:Herpesvirus 3, Human / Q000276:immunology*; D006801:Humans; D007223:Infant; D007676:Kidney Failure, Chronic / Q000276:immunology*; D007938:Leukemia / Q000276:immunology*; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology*; D012306:Risk; D014613:Vaccines, Attenuated / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*
D000914:Antibodies, Viral; D014613:Vaccines, Attenuated; D014765:Viral Vaccines